Indraprastha Medical Corporation Limited has informed the Exchange that Board of Directors at its meeting held on May 16, 2025, recommended Final Dividend of 4.50 per equity share.
INDRAMEDCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Indraprastha Medical Corporation (Indraprastha Apollo Hospitals) approved audited financial results for FY24-25 and recommended a final dividend of Rs. 4.50 per share (45%), unchanged from the previous year. Revenue from operations grew to Rs. 1,356.36 crore from Rs. 1,244.70 crore, up about 9% year-on-year. Profit after tax rose to Rs. 160.99 crore from Rs. 123.96 crore, a growth of nearly 30%, while EPS improved to Rs. 17.56 from Rs. 13.52. Statutory auditors S.N. Dhawan & Co LLP issued an unmodified (clean) opinion on the results. The company also confirmed it is not classified as a Large Corporate and has NIL qualified borrowings.
Strong earnings growth and steady dividend payout are positive signals for shareholders. The unchanged dividend despite a sharp jump in profits may lead to calls for higher payouts going forward, while the clean audit and zero-debt status reinforce financial stability.